In November 2018, the Trump Administration proposed a rule that would weaken patient protections within Medicare’s Part D prescription drug benefit. Currently, Medicare Part D drug plans are required to comply with the “protected drug classes” policy, which ensure that beneficiaries have access to “all or substantially all” drugs in six specific classes of medicines (like antiretrovirals, antidepressants, antipsychotics, and anticonvulsant agents).
On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Assemblyman James Ramos (D-Highland). We look forward to working with Assemblyman Ramos and his team to advance policies that improve patient health and bring positive change for California patients and their families.
In the coming weeks, legislation will be introduced to permanently repeal the medical device excise tax.
On Wednesday, Feb. 20, California Attorney General Xavier Becerra and Chair of Assembly Health, Assemblymember Jim Wood, held a press conference to announce the introduction of legislation, Assembly Bill (AB) 824 (Wood), aimed at enabling the California Department of Justice (DOJ) to go after so-called “pay-for-delay” agreements.
On Tuesday, Feb. 26, members and representatives of the CLSA Board visited the State Capitol to meet with Governor’s Office staff and legislators from both Senate and Assembly chambers.
Assemblyman Rob Bonta, Co-Chair of the California Legislative Rare Disease Caucus, pens an op-ed in The Sacramento Bee on the need to raise awareness and help California develop strong public policies to streamline the drug development pipeline and ensure that everyone with a rare disease gets the treatment they deserve.
On Feb. 26, CLSA honored three California State Legislators as Life Sciences Champions during its legislative Back to Session Reception and Board Dinner in in Sacramento,
On Feb. 7, the CLSA’s federal government relations team hosted 10 members of CLSA’s board of directors and President & CEO, Mike Guerra, for a full day on Capitol Hill meeting with 9 members of the California delegation.
On February 12th, Governor Newsom delivered his first State of the State address, and a significant portion of the address was dedicated to the cost of and access to healthcare in California. The governor addressed the rising cost of healthcare in his speech and reiterated his plans to pave the road for a single-payer system in California.